GlaxoSmithKline
British watchdog launches criminal probe into GSK over bribery
28 May 2014
The UK Serious Fraud Office (SFO) has launched a criminal investigation into drug giant GlaxoSmithKline (GSK) over alleged bribery in China and in other countries
GSK’s former China head charged with bribery
14 May 2014
GSK said that some of its senior Chinese executives appeared to have broken the law
Novartis AG, GSK in $23-bn assets swap deal
22 Apr 2014
Swiss drug giant Novartis AG and Britain's GlaxoSmithKline Plc (GSK) today announced a swap of assets in a deal valued at around $23 billion
After China, Iraq, Poland, GSK bribery probe now expands to Jordan, Lebanon
17 Apr 2014
The probe into a whistle-blower's allegations that British drug giant GlaxoSmithKline’s employees bribed doctors to prescribe its products has now expanded to the Middle East
After China and Iraq, GSK now faces bribery probe in Poland
14 Apr 2014
British drug giant GlaxoSmithKline (GSK), is under a criminal probe for allegedly bribing doctors in Poland for prescribing its asthma drug Seretide
GSK spends $1.05 bn to raise stake in Indian arm
11 Mar 2014
GlaxoSmithKline Plc (GSK) yesterday said that it has paid £625 million ($1.05 billion) to increase its stake in its Indian subsidiary GSK Pharmaceuticals to 75 per cent
